Tag: Carthera
Carthera enrols first patient in trial assessing novel recurrent glioblastoma treatment
Carthera has announced the enrolment of the first patient in the SONOBIRD pivotal trial assessing its ultrasound-based Sonocloud medical device for the treatment of...
Carthera publishes “promising” results with SonoCloud-9 in glioblastoma patients
Carthera has announced the publication in The Lancet Oncology of results from a Phase 1 clinical trial carried out by scientists at Northwestern University...
Carthera and US FDA align on key aspects of potential pivotal...
Carthera, which develops the Sonocloud—an ultrasound-based medical device used to treat a wide range of brain diseases—has announced today the completion of an end-of-Phase...
Carthera receives FDA Breakthrough Device designation for Sonocloud-9 system
Carthera announced today that its Sonocloud-9 system has been listed as a Breakthrough Device by the Center for Devices and Radiological Health (CDRH) at...
Sonocloud technology demonstrates safety and therapeutic potential in Alzheimer’s patients
Carthera has announced today the publication of results from an investigator-sponsored pilot clinical trial evaluating safety and efficacy using its Sonocloud technology in patients...
